Meeting
2018 ASCO-SITC Clinical Immuno-Oncology Symposium
Correlation of lung cancer mutational profile with immune profile.
Authors
Antonios Papanicolau-Sengos
OmniSeq, Inc., Buffalo, NY
Antonios Papanicolau-Sengos, Sarabjot Pabla, Grace K. Dy, Marc S. Ernstoff, Igor Puzanov, Jeffrey M. Conroy, Mary Nesline, Sean T. Glenn, Blake Burgher, Jonathan Andreas, Vincent Giamo, Maochun Qin, Felicia L. Lenzo, Mark Gardner, Carl Morrison
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Developmental Therapeutics,Genitourinary Cancer,Head and Neck Cancer,Lung Cancer,Melanoma/Skin Cancers,Gastrointestinal Cancer,Breast and Gynecologic Cancers,Combination Studies,Implications for Patients and Society,Miscellaneous Cancers,Oncolytic Viruses,Hematologic Malignancies
Sub Track
Biomarkers and Inflammatory Signatures
Citation
J Clin Oncol 36, 2018 (suppl 5S; abstr 146)
DOI
10.1200/JCO.2018.36.5_suppl.146
Abstract #
146
Poster Bd #
H6
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
Immune marker profiling and PD-L1, PD-L2 expression mechanisms across non-small cell lung cancer mutations.
First Author: Maria Toki
Poster
2015 ASCO Annual Meeting
Clinicopathological and molecular parameters of lung adenocarcinomas (ADC) associated with programmed cell death ligand 1 (PD-L1) protein expression.
First Author: Tiffany Huynh
Poster
2014 ASCO Annual Meeting
PD-L1 expression and genotype in non-small cell lung cancer (NSCLC).
First Author: Sascha Ansen
Poster
2014 ASCO Annual Meeting
Combined immunophenotyping of tumor-infiltrating lymphocytes as a prognostic factor in resected patients with non-small cell lung cancer.
First Author: Ross A. Soo